A class of drugs called BACE1 inhibitors, originally designed to treat Alzheimer's disease, shows potential for the treatment of glioblastoma brain cancer.
Drug Designed for Alzheimer's Disease May Hold Promise for Treating Glioblastoma
Neuroscience News - 27 Nov 2021 01:41
A class of drugs called BACE1 inhibitors, originally designed to treat Alzheimer's disease, shows potential for the treatment of glioblastoma brain cancer.
Share this Article
Recommended